Lexicon Pharmaceuticals (LXRX) EBITDA Margin (QoQ) (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
27,700.00 |
| Dec 31, 2025 |
-19,297.00 |
| Sep 30, 2025 |
-10,086.00 |
| Jun 30, 2025 |
202,294.00 |
| Mar 31, 2025 |
-188,378.00 |
| Dec 31, 2024 |
354,449.00 |
| Sep 30, 2024 |
-41,981.00 |
| Jun 30, 2024 |
118,261.00 |
| Mar 31, 2024 |
204,145.00 |
| Dec 31, 2023 |
2.47 Mn |
| Sep 30, 2023 |
-1.71 Mn |
| Jun 30, 2021 |
6.99 Mn |
| Mar 31, 2021 |
-7.76 Mn |
| Jun 30, 2020 |
-27.77 Mn |
| Mar 31, 2020 |
-23,762.00 |
| Dec 31, 2019 |
-66,219.00 |
| Sep 30, 2019 |
31,396.00 |
| Jun 30, 2019 |
65,465.00 |
| Mar 31, 2019 |
-79,387.00 |
| Dec 31, 2018 |
29,320.00 |
